Bristol Glucophage Petition Seeks FDA Hearing Before ANDA Approval
Executive Summary
FDA should conduct a public proceeding to determine appropriate labeling for generic metformin before approving ANDAs for versions of Bristol-Myers Squibb's Glucophage, the company argues in a citizen petition submitted to FDA Dec. 26
You may also be interested in...
ANDA Approvals In 2002 Could Affect Over $10 Bil. In Brand Sales
Branded products representing more than $10 bil. in annual sales are vulnerable to first generic competition in 2002
Barr Expects Metformin Launch By Early February; Pediatric Bill Signed
Barr plans to launch its generic version of Bristol-Myers Squibb's Glucophage (metformin) by early February, CEO Bruce Downey said Jan. 10
ANDA Approvals In 2002 Could Affect Over $10 Bil. In Brand Sales
Branded products representing more than $10 bil. in annual sales are vulnerable to first generic competition in 2002